BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 23
• 24
• 27
• 28

• Can AI Help Extend Your Life Span? Gachon University Study

  February 7, 2017

   · 

  1 min read
• BioCapital

  Top 4 Challenges To Biosimilar Growth

  February 7, 2017

   · 

  1 min read
• 

  Drug Development

  No Looking Back: Cellectis Preps for Cutting-Edge ‘Off-the-Shelf’ CAR-T Trial

  February 7, 2017

   · 

  2 min read
• BioMidwest

  One Of The Largest Middlemen In Pharma Just Shed A Little Light On The Murky World Of Drug Pricing

  February 7, 2017

   · 

  1 min read
• BioCapital

  Here’s What Everyone In The Drug Industry Is Talking About Right Now

  February 7, 2017

   · 

  1 min read
• Policy

  BioMarin Files Lawsuit to Block the Generic Form of Its $90,000-Per-Year Drug

  February 7, 2017

   · 

  1 min read
• 

  Merck KGaA Spinout Prexton Nabs $31 Million to Fund Phase II Parkinson’s Trials

  February 7, 2017

   · 

  3 min read
• 

  Biotech Bay

  4 Biotech Stocks Worthy Enough to be Brokers’ Favorites

  February 7, 2017

   · 

  2 min read
• 

  FDA

  Genentech’s $94,000-a-Year Drug Tarceva: Why Faster FDA Approvals Could Backfire

  February 7, 2017

   · 

  4 min read
• Business

  Marathon Pharma And Italfarmaco Join cTAP: Learning From Patient Data To Enhance Clinical Trial Design For Duchenne Muscular Dystrophy

  February 7, 2017

   · 

  5 min read